Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-17-004750

Chief Financial Officer bought 3,333 shares at $4.50 ($14,999)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tulipano Stephen J Chief Financial Officer 2017-02-17 Purchase +3,333 $4.50 $14,999 3,333 D
Open-market purchases · 3,333 sh · avg $4.50 · $14,999
Loading xslF345X03/doc4.xml…